Published Scientific Articles
Inflammatory Mediators of Esophagitis Alter p27Kip1 Expression in Esophageal Epithelial Cells
Tyrosine phosphorylation of the p21 cyclin-dependent kinase inhibitor facilitates the development of proneural glioma
Brk/Protein tyrosine kinase 6 phosphorylates p27KIP1, regulating the activity of cyclin D-cyclin-dependent kinase 4
Dual Inhibition of CDK4 and CDK2 via Targeting p27 Tyrosine Phosphorylation Induces a Potent and Durable Response in Breast Cancer Cells
Concarlo in the News
Life Sciences Review special edition on BioTech Startup 2022
US biotech start-up set to have huge impact on breast cancer treatment landscape
Concarlo: targeting proliferation and resistance in one go
Patent awarded for Concarlo-developed therapeutic to tackle treatment-resistant breast cancer
Webinars & Talks
Concarlo is on a Mission to Rid the World of Metastatic Breast Cancer
Opportunity to Join the Fight Against Metastatic Breast Cancer
LabOps: Changing Outcomes for Drug-Resistant Patients with Stacy Blain, Founder, and CSO at Concarlo Therapeutics
Beyond Biotech podcast 24: Concarlo Therapeutics
Awards
“The reward for work well done is the opportunity to do more”
—Jonas Salk
RESI’s Innovator’s Pitch Challenge Winner
Princeton University Women’s Showcase
The 50 Most admired companies: CIO Bio
Top 100 entreprenuers: Alumni List
Top Biotech Startup 2022
Awarded by: Life Sciences Review
